共有 50 笔近期内部人交易记录记录，涉及 C4 Therapeutics, Inc. (CCCC), 包括 30 笔买入 和 20 笔卖出. 内部人买入总额为 $3.38M 内部人卖出总额为 $309.87K.
近期活跃的重要内部人包括 Grogan Donna Roy, Anderson Kenneth Carl, Hirsch Andrew. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CCCC
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-01 |
Grogan Donna Roy |
Director |
限制性股票授予 (RSU) |
5,370 |
$2.70 |
$14.5K |
71,512 |
| 2026-04-01 |
Anderson Kenneth Carl |
Director |
限制性股票授予 (RSU) |
4,259 |
$2.70 |
$11.5K |
68,230 |
| 2026-02-15 |
Hirsch Andrew |
President & CEO |
RSU 预扣税 |
9,057 |
$1.89 |
$17.12K |
1,074,934 |
| 2026-02-14 |
Reyno Leonard |
Chief Medical Officer |
RSU 预扣税 |
16,579 |
$1.89 |
$31.33K |
379,803 |
| 2026-02-14 |
Hirsch Andrew |
President & CEO |
RSU 预扣税 |
39,154 |
$1.89 |
$74K |
1,083,991 |
| 2026-02-14 |
Schick Kelly |
Chief People Officer |
RSU 预扣税 |
7,269 |
$1.89 |
$13.74K |
299,881 |
| 2026-02-14 |
Boyle Scott N |
Chief Business Officer |
RSU 预扣税 |
7,269 |
$1.89 |
$13.74K |
298,801 |
| 2026-02-14 |
Adams Kendra |
Chief Financial Officer |
RSU 预扣税 |
15,381 |
$1.89 |
$29.07K |
385,098 |
| 2026-02-14 |
Mossler Mark |
Chief Accounting Officer |
RSU 预扣税 |
3,268 |
$1.89 |
$6.18K |
71,916 |
| 2026-02-14 |
Mahaney Paige |
Chief Scientific Officer |
RSU 预扣税 |
2,446 |
$1.89 |
$4.62K |
336,910 |
| 2026-02-13 |
Reyno Leonard |
Chief Medical Officer |
限制性股票授予 (RSU) |
240,000 |
- |
- |
396,382 |
| 2026-02-13 |
Hirsch Andrew |
President & CEO |
限制性股票授予 (RSU) |
700,000 |
- |
- |
1,123,145 |
| 2026-02-13 |
Schick Kelly |
Chief People Officer |
RSU 预扣税 |
1,735 |
$1.89 |
$3.28K |
307,150 |
| 2026-02-13 |
Boyle Scott N |
Chief Business Officer |
RSU 预扣税 |
1,735 |
$1.89 |
$3.28K |
306,070 |
| 2026-02-13 |
Adams Kendra |
Chief Financial Officer |
RSU 预扣税 |
1,863 |
$1.89 |
$3.52K |
400,479 |
| 2026-02-13 |
Mossler Mark |
Chief Accounting Officer |
限制性股票授予 (RSU) |
56,980 |
- |
- |
75,184 |
| 2026-02-13 |
Mahaney Paige |
Chief Scientific Officer |
限制性股票授予 (RSU) |
240,000 |
- |
- |
339,356 |
| 2026-01-16 |
Reyno Leonard |
Chief Medical Officer |
知情卖出 |
10,000 |
$2.22 |
$22.2K |
156,382 |
| 2026-01-02 |
Grogan Donna Roy |
Director |
限制性股票授予 (RSU) |
7,513 |
$1.93 |
$14.5K |
66,142 |
| 2026-01-02 |
Anderson Kenneth Carl |
Director |
限制性股票授予 (RSU) |
5,958 |
$1.93 |
$11.5K |
146,532 |
| 2025-10-28 |
Mahaney Paige |
Chief Scientific Officer |
RSU 预扣税 |
5,644 |
$2.58 |
$14.56K |
99,356 |
| 2025-10-01 |
Grogan Donna Roy |
Director |
限制性股票授予 (RSU) |
6,740 |
$2.15 |
$14.49K |
58,629 |
| 2025-10-01 |
Anderson Kenneth Carl |
Director |
限制性股票授予 (RSU) |
5,349 |
$2.15 |
$11.5K |
140,574 |
| 2025-09-18 |
Adams Kendra |
Chief Financial Officer |
RSU 预扣税 |
2,775 |
$3.32 |
$9.21K |
162,342 |
| 2025-07-10 |
Reyno Leonard |
Chief Medical Officer |
RSU 预扣税 |
7,382 |
$1.99 |
$14.69K |
166,382 |
| 2025-07-10 |
Reyno Leonard |
Chief Medical Officer |
期权行权 |
15,325 |
- |
- |
173,764 |
| 2025-07-01 |
Grogan Donna Roy |
Director |
限制性股票授予 (RSU) |
9,609 |
$1.51 |
$14.51K |
51,889 |
| 2025-07-01 |
Anderson Kenneth Carl |
Director |
限制性股票授予 (RSU) |
7,616 |
$1.51 |
$11.5K |
135,225 |
| 2025-06-18 |
Hoerter Steven L. |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-06-18 |
Hughes Owen |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-06-18 |
Cooper Ronald Harold Wilfred |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-06-18 |
Koppikar Utpal |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-06-18 |
Grogan Donna Roy |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-06-18 |
Anderson Kenneth Carl |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-06-18 |
Bessen Laura |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-06-18 |
Fawell Stephen |
Director |
限制性股票授予 (RSU) |
35,500 |
$1.44 |
$51.12K |
35,500 |
| 2025-04-01 |
Grogan Donna Roy |
Director |
限制性股票授予 (RSU) |
9,581 |
$1.44 |
$13.75K |
42,280 |
| 2025-04-01 |
Anderson Kenneth Carl |
Director |
限制性股票授予 (RSU) |
7,841 |
$1.44 |
$11.25K |
127,609 |
| 2025-02-18 |
Boyle Scott N |
Chief Business Officer |
知情卖出 |
669 |
$3.15 |
$2.11K |
107,805 |
| 2025-02-15 |
Hirsch Andrew |
President & CEO |
RSU 预扣税 |
9,370 |
$3.18 |
$29.8K |
423,145 |
| 2025-02-14 |
Reyno Leonard |
Chief Medical Officer |
限制性股票授予 (RSU) |
130,600 |
$3.18 |
$415.31K |
130,600 |
| 2025-02-14 |
Hirsch Andrew |
President & CEO |
限制性股票授予 (RSU) |
335,300 |
$3.18 |
$1.07M |
335,300 |
| 2025-02-14 |
Siegel Jolie |
Chief Legal Officer |
限制性股票授予 (RSU) |
84,700 |
$3.18 |
$269.35K |
84,700 |
| 2025-02-14 |
Schick Kelly |
Chief People Officer |
限制性股票授予 (RSU) |
84,700 |
$3.18 |
$269.35K |
84,700 |
| 2025-02-14 |
Boyle Scott N |
Chief Business Officer |
限制性股票授予 (RSU) |
84,700 |
$3.18 |
$269.35K |
84,700 |
| 2025-02-14 |
Adams Kendra |
Chief Financial Officer |
限制性股票授予 (RSU) |
130,600 |
$3.18 |
$415.31K |
130,600 |
| 2025-02-14 |
Mossler Mark |
Chief Accounting Officer |
RSU 预扣税 |
1,586 |
$3.18 |
$5.04K |
18,204 |
| 2025-02-14 |
Mahaney Paige |
Chief Scientific Officer |
限制性股票授予 (RSU) |
42,400 |
$3.18 |
$134.83K |
42,400 |
| 2025-02-13 |
Siegel Jolie |
Chief Legal Officer |
RSU 预扣税 |
2,135 |
$3.20 |
$6.83K |
54,353 |
| 2025-02-13 |
Schick Kelly |
Chief People Officer |
RSU 预扣税 |
1,735 |
$3.20 |
$5.55K |
54,753 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
